The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Companion Animal Drugs Market Research Report 2024

Global Companion Animal Drugs Market Research Report 2024

Publishing Date : Jan, 2024

License Type :

Report Code : 1887844

No of Pages : 87

Ask Your Query

Report Description
Table of Content

Synopsis

The global Companion Animal Drugs market was valued at US$ 26770 million in 2023 and is anticipated to reach US$ 33550 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age.

And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 24%.

This report aims to provide a comprehensive presentation of the global market for Companion Animal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Animal Drugs.

Report Scope

The Companion Animal Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Companion Animal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Companion Animal Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Zoetis
Bayer
Boehringer Ingelheim
Eli Lilly
Merck
Vetoquinol
Virbac
Dechra Pharmaceuticals
Ceva Sante Animale
Aratana Therapeutics

Segment by Type

Antibiotics and Antimicrobials
Parasiticides
Others

Segment by Application

Dogs
Cats
Horses
Others

By Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Animal Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Animal Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibiotics and Antimicrobials
1.2.3 Parasiticides
1.2.4 Others
1.3 Market by Application
1.3.1 Global Companion Animal Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Dogs
1.3.3 Cats
1.3.4 Horses
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Animal Drugs Market Perspective (2019-2030)
2.2 Companion Animal Drugs Growth Trends by Region
2.2.1 Global Companion Animal Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Companion Animal Drugs Historic Market Size by Region (2019-2024)
2.2.3 Companion Animal Drugs Forecasted Market Size by Region (2025-2030)
2.3 Companion Animal Drugs Market Dynamics
2.3.1 Companion Animal Drugs Industry Trends
2.3.2 Companion Animal Drugs Market Drivers
2.3.3 Companion Animal Drugs Market Challenges
2.3.4 Companion Animal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Animal Drugs Players by Revenue
3.1.1 Global Top Companion Animal Drugs Players by Revenue (2019-2024)
3.1.2 Global Companion Animal Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Companion Animal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Animal Drugs Revenue
3.4 Global Companion Animal Drugs Market Concentration Ratio
3.4.1 Global Companion Animal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Animal Drugs Revenue in 2023
3.5 Companion Animal Drugs Key Players Head office and Area Served
3.6 Key Players Companion Animal Drugs Product Solution and Service
3.7 Date of Enter into Companion Animal Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Animal Drugs Breakdown Data by Type
4.1 Global Companion Animal Drugs Historic Market Size by Type (2019-2024)
4.2 Global Companion Animal Drugs Forecasted Market Size by Type (2025-2030)
5 Companion Animal Drugs Breakdown Data by Application
5.1 Global Companion Animal Drugs Historic Market Size by Application (2019-2024)
5.2 Global Companion Animal Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Companion Animal Drugs Market Size (2019-2030)
6.2 North America Companion Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Companion Animal Drugs Market Size by Country (2019-2024)
6.4 North America Companion Animal Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Companion Animal Drugs Market Size (2019-2030)
7.2 Europe Companion Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Companion Animal Drugs Market Size by Country (2019-2024)
7.4 Europe Companion Animal Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Animal Drugs Market Size (2019-2030)
8.2 Asia-Pacific Companion Animal Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Companion Animal Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Companion Animal Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Companion Animal Drugs Market Size (2019-2030)
9.2 Latin America Companion Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Companion Animal Drugs Market Size by Country (2019-2024)
9.4 Latin America Companion Animal Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Animal Drugs Market Size (2019-2030)
10.2 Middle East & Africa Companion Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Companion Animal Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Companion Animal Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Companion Animal Drugs Introduction
11.1.4 Zoetis Revenue in Companion Animal Drugs Business (2019-2024)
11.1.5 Zoetis Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Companion Animal Drugs Introduction
11.2.4 Bayer Revenue in Companion Animal Drugs Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Companion Animal Drugs Introduction
11.3.4 Boehringer Ingelheim Revenue in Companion Animal Drugs Business (2019-2024)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Companion Animal Drugs Introduction
11.4.4 Eli Lilly Revenue in Companion Animal Drugs Business (2019-2024)
11.4.5 Eli Lilly Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Companion Animal Drugs Introduction
11.5.4 Merck Revenue in Companion Animal Drugs Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Vetoquinol
11.6.1 Vetoquinol Company Detail
11.6.2 Vetoquinol Business Overview
11.6.3 Vetoquinol Companion Animal Drugs Introduction
11.6.4 Vetoquinol Revenue in Companion Animal Drugs Business (2019-2024)
11.6.5 Vetoquinol Recent Development
11.7 Virbac
11.7.1 Virbac Company Detail
11.7.2 Virbac Business Overview
11.7.3 Virbac Companion Animal Drugs Introduction
11.7.4 Virbac Revenue in Companion Animal Drugs Business (2019-2024)
11.7.5 Virbac Recent Development
11.8 Dechra Pharmaceuticals
11.8.1 Dechra Pharmaceuticals Company Detail
11.8.2 Dechra Pharmaceuticals Business Overview
11.8.3 Dechra Pharmaceuticals Companion Animal Drugs Introduction
11.8.4 Dechra Pharmaceuticals Revenue in Companion Animal Drugs Business (2019-2024)
11.8.5 Dechra Pharmaceuticals Recent Development
11.9 Ceva Sante Animale
11.9.1 Ceva Sante Animale Company Detail
11.9.2 Ceva Sante Animale Business Overview
11.9.3 Ceva Sante Animale Companion Animal Drugs Introduction
11.9.4 Ceva Sante Animale Revenue in Companion Animal Drugs Business (2019-2024)
11.9.5 Ceva Sante Animale Recent Development
11.10 Aratana Therapeutics
11.10.1 Aratana Therapeutics Company Detail
11.10.2 Aratana Therapeutics Business Overview
11.10.3 Aratana Therapeutics Companion Animal Drugs Introduction
11.10.4 Aratana Therapeutics Revenue in Companion Animal Drugs Business (2019-2024)
11.10.5 Aratana Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Medical Coatings Market - Industry Trends and Forecast to 2031

Global Pediatric MRI Systems Market Research Report 2024

Global Oridonin Market Research Report 2024

Global Dual Fetal Monitors Market Research Report 2024

Global Animal Examination Otoscopes Market Research Report 2024

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}